Cardiovascular disease remains a leading global health burden, yet many preclinical systems still struggle to predict how candidate drugs will perform in the human heart.
LONDON--(BUSINESS WIRE)--The prevalence of cardiac arrhythmias has increased significantly in recent years, owing to the increased risk of stroke and hospitalizations. This is encouraging various ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results